Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mevacor in Rett syndrome
NCT02563860Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of lovastatin in Rett syndrome (RTT), sponsored by Montefiore Medical Center. Primary endpoint: Gait Velocity at 32 weeks. Started Jul 2015; status: completed.
02
Drugs
lovastatin
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT02563860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563860.